Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Dermatologists
... in group practices or as solo practitioners; some work for hospitals, medical schools, or outpatient facilities. COMPETITIVE LANDSCAPE Demand for dermatologists is driven by demographics and population growth. The profitability of dermatology practices depends on ... Read More
-
Europe Pharmaceutical Cold Chain Logistics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... is expected to reach USD 31.32 billion by 2029, growing at a CAGR of 10% during the forecast period (2024-2029). Europe is home to some of the largest pharmaceutical and life sciences companies, including Roche ... Read More
-
Global Arbidol Tablets (COVID-19) Market Growth 2024-2030
... the Arbidol Tablets (COVID-19) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Arbidol Tablets ... Read More
-
Global Traditional Chinese Medicine for COVID-19 Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2030, growing at a CAGR of % over the analysis period. Traditional Chinese medicine (TCM) for COVID-19 refers to herbal remedies and formulations used in traditional Chinese medicine to support recovery and manage symptoms ... Read More
-
Global Arbidol Hydrochloride (COVID-19) Market Growth 2024-2030
... the Arbidol Hydrochloride (COVID-19) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Arbidol Hydrochloride ... Read More
-
Global COVID-19 Isopropyl Alcohol Disinfectant Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Isopropyl alcohol (2-propanol), also known as isopropanol or IPA, is the ... Read More
-
MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
-
Torii Pharmaceutical Co Ltd (4551) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Vimta Labs Ltd (VIMTALABS) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Kineta Inc (KANT) - Financial and Strategic SWOT Analysis Review
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
-
Traws Pharma Inc (TRAW) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Global Biotech Ingredients Market Size Study, by Type (Active Pharmaceutical Ingredients, Biosimilars), by Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), by Expression Systems (Mammalian, Microbial, Yeast, Plant, Insect), and Regional Forecasts 2022-2032
... Insect), and Regional Forecasts 2022-2032 Global Biotech Ingredients Market was valued at approximately USD 59.10 billion in 2023 and is expected to grow at a CAGR of 4.81% during the forecast period of 2024 to ... Read More
-
Harrow Inc (HROW) - Financial and Strategic SWOT Analysis Review
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
-
Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More
-
Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Zilosul Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... yields glucurono-xylans, which are then sulfated to create a negatively charged substance that resembles glycosaminoglycans (GAGs). GAGs are complex carbohydrates that interact with proteins involved in inflammatory processes, thereby regulating various bodily functions. PPS is ... Read More
-
Herpes Zoste Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application
... from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented from 2019 ... Read More
-
X0002 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... (OA) and rheumatoid arthritis. This novel drug is being evaluated for its effectiveness in delivering pain relief and anti-inflammatory effects directly through the skin. A Phase III clinical trial, TF-X0002-31 (Freedom-1), has been initiated at ... Read More
-
Asia-pacific Dry Eye Disease Market Forecast (2024-2032)
... $1216.91 million in 2023, reaching a revenue of $1987.33 million by 2032. MARKET INSIGHTS Factors such as the increasing prevalence of dry eye disease and a rising demand for dry eye disease treatment products are ... Read More
-
Global Dry Eye Disease Market Forecast 2024-2032
... was valued at $5673.53 million in 2023, reaching a revenue of $8884.34 million by 2032. Dry eye disease is a chronic, progressive syndrome affecting millions globally, with the incidence rising significantly with age. As the ... Read More
-
Japan Dry Eye Disease Market Forecast 2024-2032
... reaching an expected revenue of $401.68 million by 2032. The rising prevalence of dry eye diseases in Japan is linked to modern lifestyle factors such as increased screen exposure and environmental pollution, which significantly contribute ... Read More
-
China Dry Eye Disease Market Forecast 2024-2032
... with projected revenue reaching $643.91 million by 2032. The market’s expansion is driven by a combination of factors, including the rising prevalence of dry eye diseases, lifestyle changes, and an increasing demand for dry eye ... Read More
-
Europe Dry Eye Disease Market Forecast 2024-2032
... $1686.02 million in 2023, reaching a revenue of $2569.11 million by 2032. MARKET INSIGHTS The Europe dry eye disease market is set for consistent growth, driven by the aging population, increasing demand for dry eye ... Read More
Research Assistance
